Effect of Samarium on the Relief of Pain Due to Vertebral Metastases
Phase I/II Study of the Use of Vertebral Intracavitary Cement and Samarium (VICS) for Painful Vertebral Metastases
Sponsor: New York Presbyterian Brooklyn Methodist Hospital
This PHASE1/PHASE2 trial investigates Cancer and Metastasis and is currently completed. New York Presbyterian Brooklyn Methodist Hospital leads this study, which shows 7 recorded versions since 2006 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1_PHASE2
-
Sep 2019 — Jan 2021 [monthly]
Completed PHASE1_PHASE2
-
Jun 2018 — Sep 2019 [monthly]
Completed PHASE1_PHASE2
▶ Show 2 earlier versions
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE1_PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE1_PHASE2
First recorded
May 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- New York Presbyterian Brooklyn Methodist Hospital
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Brooklyn, United States